TCTR20211012001
Completed
Not Applicable
The study of the treatment efficacy in prostate cancer with low dose abiraterone
/A0 sites21 target enrollmentOctober 12, 2021
ConditionsProstate cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- /A
- Enrollment
- 21
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Metastatic prostate cancer patients who are not previously received chemotherapy.
- •2\. Patients agree to consent for the study.
- •3\. ECOG performance status 0\-2
Exclusion Criteria
- •1\. Patient who has prior treatment with abiraterone or enzalutamide.
- •2\. Patient who has received treatment with drug or other procedure such as
- •radiation therapy and radionuclear Radium 223 method.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A real world study on the treatment of prostate cancer by integrated Chinese and Western medicineProstate cancerITMCTR2200006847Guangdong Provincial Hospital of Chinese Medicine
Recruiting
Not Applicable
Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)Prostate cancer patients with bone metastasisJPRN-UMIN000011648Osaka University160
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
Completed
Not Applicable
Outcome study of hormonal therapy for prostate cancer in JapaJPRN-C000000252J-CaP study group24,000
Not yet recruiting
Not Applicable
Evaluation of safety and efficacy in prostate cancer patients treated with focal low-dose-rate brachytherapyProstate cancerJPRN-UMIN000030509Kitasato University School of Medicine, Department of Urology20